Incidensen af hypoglykæmi ved behandling med BYETTA i kombination med et thiazolidindion er sammenlignelig med den for kombinationen af placebo og et thiazolidindion.
When BYETTA was used in combination with a thiazolidinedione, the incidence of hypoglycaemia was similar to that of placebo in combination with a thiazolidinedione.